DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.

Area of Science:

• Molecular Biology
• Cancer Research
• Neuroscience

Background:

• The p53 family, including p73, is crucial for neural development and tumor suppression.
• p73 exists as two isoforms, TAp73 and ΔNp73, with often opposing functions.
• DEC1 is a known target of the p53 family, suggesting a role in regulating p73 activity.

Purpose of the Study:

• To investigate the distinct regulatory roles of DEC1 on TAp73 and ΔNp73 expression.
• To elucidate the underlying molecular mechanisms of DEC1-mediated regulation.
• To explore the potential therapeutic implications of this regulatory pathway.

Main Methods:

• Analysis of TAp73 and ΔNp73 promoter activity.
• Investigation of DEC1's interaction with HDAC8.
• Assessment of DEC1 and HDAC8 recruitment to p73 promoters.
• Functional studies in the presence and absence of HDAC8.

Main Results:

• DEC1 activates TAp73 transcription and represses ΔNp73 transcription.
• HDAC8 is essential for DEC1 to enhance TAp73 expression.
• DEC1 interacts with HDAC8 and recruits it to the TAp73 promoter, but not the ΔNp73 promoter.
• Differential regulation of TAp73 and ΔNp73 by DEC1 and HDAC8 was demonstrated.

Conclusions:

• DEC1 and HDAC8 collaborate to differentially regulate TAp73 and ΔNp73 expression.
• This distinct regulation provides a potential basis for therapeutic strategies to improve tumor cell chemosensitivity.